title: Omacor effects on serum lipids and clinical outcome.
authors.forename: Matthew K
authors.initials: MK
authors.lastname: Ito
authors.forename: Joel
authors.initials: J
authors.lastname: Marrs
authors.forename: Craig
authors.initials: C
authors.lastname: Williams
mesh_terms: D004281:Docosahexaenoic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000188:drug therapy*; D014280:Triglycerides / Q000097:blood*
chemical_list: D004338:Drug Combinations; D015525:Fatty Acids, Omega-3; D014280:Triglycerides; D004281:Docosahexaenoic Acids; D015118:Eicosapentaenoic Acid; C405603:Omacor